Zentiva Strikes Deal To Buy UK’s Creo Pharmaceuticals As It Pursues ‘Champion’ Ambitions

Zentiva has announced it is buying the UK’s Creo Pharmaceuticals from Amneal Pharmaceuticals as it pursues its goal of becoming a European generics leader.

Winner
Zentiva Is Seeking To Become A European ‘Champion’ • Source: Shutterstock

Czech generics company Zentiva Group has begun bulking up on acquisitions and says it is on the lookout for more opportunities as it seeks to become “the champion of generics in Europe” under its new owner, private-equity giant Advent International.

Zentiva, which has a strong presence in Eastern Europe, particularly in the Czech Republic, Slovakia and Romania, announced it is...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business